Cone Health Women's Hospital

Kaiser Permanente Bernard J. Tyson School of Medicine appoints Dr. John L. Dalrymple as new Dean and CEO

Retrieved on: 
Mardi, avril 16, 2024
Education, Harvard University, University, Reproductive biology, Moses Austin, Medical school, Hospital, Teaching, School, Health, Doctor of Philosophy, Brigham, Dell Medical School, MD Anderson Cancer Center, History, Medical education, OBGYN, Curriculum, Cone Health Women's Hospital, Dalrymple, Medicine, Ellen, Faculty, Harvard Medical School, Student, Massachusetts General Hospital, Nursing

PASADENA, Calif., April 16, 2024 /PRNewswire/ -- Today, the Board of Directors of the Kaiser Permanente Bernard J. Tyson School of Medicine (KPSOM) announced the appointment of physician, educator, and women's health expert John L. Dalrymple, MD, as the school's new Dean and CEO after an extensive national search. Dr. Dalrymple brings a wealth of academic leadership and teaching experience, respected expertise as a practicing physician, a proven record of delivering quality medical education and a commitment to advancing equitable healthcare. Dr. Dalrymple will begin his service as Dean and CEO on July 1, 2024.

Key Points: 
  • Dr. Dalrymple will begin his service as Dean and CEO on July 1, 2024.
  • Dr. Dalrymple currently serves as the senior associate dean for Medical Education at Harvard Medical School.
  • Together, we will ensure that our school remains at the forefront of innovation, equity, compassionate care, and excellence in medical education."
  • "I am deeply honored and immensely humbled to become part of this innovative, vibrant, and forward-thinking school and world-class healthcare organization.

St. Joseph's Children's Hospital Foundation Receives Historic $50 Million Gift from the Pagidipati Family of Tampa

Retrieved on: 
Mercredi, avril 10, 2024
Harvard University, University, Cancer, Central Florida, Hospital, Imagination, Health, Trauma, MD, Partnership, Parent, Research, Children's Hospital, HMO, Cone Health Women's Hospital, Family, Patient, St. Joseph's Hospital, Medicine, Physician, Medicare, Nursing

TAMPA, Fla., April 11, 2024 /PRNewswire/ -- St. Joseph's Children's Hospital Foundation announced today a $50 million gift from the Pagidipati family of Tampa to support the future of pediatric health care in the Tampa Bay community.

Key Points: 
  • TAMPA, Fla., April 11, 2024 /PRNewswire/ -- St. Joseph's Children's Hospital Foundation announced today a $50 million gift from the Pagidipati family of Tampa to support the future of pediatric health care in the Tampa Bay community.
  • When the new children's hospital facility opens, it will be named "Pagidipati Children's Hospital at St. Joseph's" in recognition of the generosity of the Pagidipati family.
  • The gift to St. Joseph's Children's Hospital is a celebration of the family's steadfast commitment to healing others.
  • St Joseph's Children's Hospital is home to the 24-hour Steinbrenner Emergency/Trauma Center with the region's largest team of board-certified pediatric emergency physicians.

St. Joseph's Children's Hospital Foundation Receives Historic $50 Million Gift from the Pagidipati Family of Tampa

Retrieved on: 
Mercredi, avril 10, 2024
Harvard University, University, Cancer, Central Florida, Hospital, Imagination, Health, Trauma, MD, Partnership, Parent, Research, Children's Hospital, HMO, Cone Health Women's Hospital, Family, Patient, St. Joseph's Hospital, Medicine, Physician, Medicare, Nursing

TAMPA, Fla., April 10, 2024 /PRNewswire/ -- St. Joseph's Children's Hospital Foundation announced today a $50 million gift from the Pagidipati family of Tampa to support the future of pediatric health care in the Tampa Bay community.

Key Points: 
  • TAMPA, Fla., April 10, 2024 /PRNewswire/ -- St. Joseph's Children's Hospital Foundation announced today a $50 million gift from the Pagidipati family of Tampa to support the future of pediatric health care in the Tampa Bay community.
  • When the new children's hospital facility opens, it will be named "Pagidipati Children's Hospital at St. Joseph's" in recognition of the generosity of the Pagidipati family.
  • The gift to St. Joseph's Children's Hospital is a celebration of the family's steadfast commitment to healing others.
  • St Joseph's Children's Hospital is home to the 24-hour Steinbrenner Emergency/Trauma Center with the region's largest team of board-certified pediatric emergency physicians.

MNA: Unsafe Patient Care Conditions Prompt Brigham and Women's Hospital Nurses to Picket on International Workers' Day as a Federal Mediator is Called in and Management Refuses to Negotiate a Fair Contract

Retrieved on: 
Mercredi, avril 10, 2024
Negotiation, National Nurses United, Hospital, Safety, Risk, International Workers' Day, Nursing, Workplace violence, Insurance, PACU, Violence, MGB, Cone Health Women's Hospital, Patient safety, Patient, Workforce, Brigham and Women's Hospital, MNA, Health, BWH

BOSTON, April 10, 2024 /PRNewswire/ -- The registered nurses of Brigham and Women's Hospital, represented by the Massachusetts Nurses Association (MNA), will hold an informational picket on Wednesday, May 1 as a federal mediator joins negotiations that have stretched since last summer. Nurses will advocate during the picket on International Workers' Day for a fair contract that invests in nurses and better enables them to provide safe patient care.

Key Points: 
  • Nurses will advocate during the picket on International Workers' Day for a fair contract that invests in nurses and better enables them to provide safe patient care.
  • "Our informational picket will show the public how seriously concerned almost 4,000 Brigham nurses are about MGB failing to invest in our workforce and address unsafe staffing throughout the hospital."
  • Nurses can join when they are not working or on break and will advocate for safe patient care without disrupting hospital access.
  • Nurses have delivered a petition signed by more than 3,000 nurses demanding the option to change insurance plans during annual enrollment.

Viz.ai® Announces Three New Studies Supporting Viz HCM™ Module for the Detection and Management of Suspected Hypertrophic Cardiomyopathy

Retrieved on: 
Mercredi, avril 3, 2024
Health, Technology, Hospitals, Health Technology, Software, Artificial Intelligence, Cardiology, Deep learning, FACC, Harvard Medical School, Machine learning, Cone Health Women's Hospital, PPV, Innovation, Algorithm, Artificiality, Assistant, Disease, Associate, Patient, Atlantic Health System, Triage, Salem Hospital, AI, Viz, American College, Massachusetts General Hospital, HCM, Hospital, Hypertrophic cardiomyopathy, Senior counsel, Sports cardiology, Hypertrophy, Medical director, Probability, FDA, ACC, ECG, Mass, Medical imaging

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data supporting advancements in cardiology care.

Key Points: 
  • Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data supporting advancements in cardiology care.
  • The Viz HCM module is the first and only AI algorithm cleared by the FDA for HCM.
  • The study found that Viz HCM performance in suspected HCM detection was consistent across various racial backgrounds with a sensitivity of 68.4% and specificity of 99.1%.
  • This validates the effectiveness of relevance score sorting for prioritizing higher probability HCM-positive patients identified by deep-learning algorithms analyzing ECG data.

AMERICAN SKIN ASSOCIATION ANNOUNCES NEW BOARD MEMBER JOSEPH F. MEROLA, MD, MMSc, FAAD, FACR

Retrieved on: 
Jeudi, avril 4, 2024
Cone Health Women's Hospital, Internal medicine, Patient, Skin, FAAD, Connective tissue, DSM-IV codes, Education, ASA, MDS, MMSc, Mass, Harvard Medical School, Associate, National Psoriasis Foundation, Psoriatic arthritis, Hospital, Public health, Atopic dermatitis, Dermatomyositis, Lupus, American Academy, Assessment, Management

NEW YORK, April 4, 2024 /PRNewswire/ -- American Skin Association (ASA) announced today that Joseph F. Merola, MD, MMSc, FAAD, FACR, will join its Board of Directors.

Key Points: 
  • NEW YORK, April 4, 2024 /PRNewswire/ -- American Skin Association (ASA) announced today that Joseph F. Merola, MD, MMSc, FAAD, FACR, will join its Board of Directors.
  • Distinguished Chair in Dermatology and is Professor at the Peter O'Donnell Jr. School of Public Health.
  • "We are proud to announce the addition of Dr. Joseph Merola to ASA's Board of Directors.
  • He was recently elected to the Board of the American Academy of Dermatology.

BayCare's St. Joseph's Women's Hospital Achieves Level IV Maternal Care Certification from The Joint Commission

Retrieved on: 
Jeudi, mars 21, 2024
Consensus, Mother, RN, Disease, Certification, Culture, Cone Health Women's Hospital, Level, Central Florida, Woman, Joint Commission, MLC, Mental, Partnership, Education, Verification, DNP, Patient, Mental health, Mortality, Anesthesiology, University, MBA, American College, OCC, Hospital, ACOG, Health, Nursing

TAMPA, Fla., March 21, 2024 /PRNewswire/ -- BayCare, the leading health care system in West Central Florida, today announced that St. Joseph's Women's Hospital has attained the highest level of certification in Maternal Care by The Joint Commission, the nation's oldest health care accrediting organization.

Key Points: 
  • TAMPA, Fla., March 21, 2024 /PRNewswire/ -- BayCare, the leading health care system in West Central Florida, today announced that St. Joseph's Women's Hospital has attained the highest level of certification in Maternal Care by The Joint Commission, the nation's oldest health care accrediting organization.
  • As a Level IV maternal care verified facility, St. Joseph's Women's Hospital is recognized for its commitment to providing exceptional maternal healthcare services.
  • "The Joint Commission commends St. Joseph's Women's Hospital for being named a Level IV maternal care verified facility and for its efforts to standardize maternal care and reduce maternal morbidity and mortality," says Ken Grubbs, DNP, MBA, RN, executive vice president of Accreditation and Certification Operations and chief nursing officer, The Joint Commission.
  • "The Maternal Levels of Care Verification program will help St. Joseph's Women's Hospital strengthen regionalized care for mothers and babies in its community."

Ibex Presents New Data from Multiple Studies Showcasing Accuracy of AI in Prostate, Breast and Gastric Cancer Diagnosis

Retrieved on: 
Jeudi, mars 21, 2024
Diagnosis, Champalimaud Foundation, Cone Health Women's Hospital, PPV, Glomus tumor, Adenoma, Overdiagnosis, Incidence, Research, Cancer, Hospital, UPMC, Breast, Marie Cassidy, AI, University, Laboratory, MD, Oncology, Medicine, USCAP, OSU, Dysplasia, Brigham and Women's Hospital, Breast cancer, Ohio State University, Pathology, Champalimaud, Stomach, Artificial intelligence, Annual general meeting, NPV, Medical imaging

BOSTON, March 21, 2024 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced excellent results across multiple clinical studies conducted with the University of Pittsburgh Medical Center (UPMC), Brigham and Women's Hospital, Champalimaud Foundation and Ohio State University (OSU). These studies, highlighting the value of Ibex's AI-powered cancer diagnostics solutions in both diagnostic quality and efficiency, will be presented next week at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting.

Key Points: 
  • Brigham and Women's Hospital and Champalimaud Foundation research shows high accuracy levels of Galen Breast in identifying microinvasive carcinoma of the breast.
  • Ohio State University Wexner Medical Center studies show high accuracy for Galen Breast and Galen Gastric in detecting and distinguishing between different types of cancer and in identifying multiple important pathologies.
  • In addition, researchers from OSU Wexner Medical Center will present studies validating Galen Breast's performance in detecting different types of breast cancer.
  • Ibex will be showcasing these findings at the USCAP Annual Meeting taking place in Baltimore, Maryland, between March 23 to 28, at booth number 755.

Advancing Skin Cancer Detection: American Academy of Dermatology Journal Publishes DermaSensor's Breakthrough Melanoma Detection Results From A Major, Multicenter Trial

Retrieved on: 
Mercredi, février 28, 2024
Software, Research, Hardware, Pharmaceutical, Oncology, Technology, Medical Devices, Health Technology, Clinical Trials, Science, Medical Supplies, Practice Management, Health, VA Boston Healthcare System, Skin cancer, Melanoma, NPV, Principal, Physician, FDA, Integral, Hospital, Assessment, Skin, Negative, Patient, Journal, Cone Health Women's Hospital, Harvard Medical School, American Academy, Medical device

In addition, the Negative Predictive Value (NPV) of 98.1% (95% CI, 91.8%-99.6%) indicates a high level of reliability for a negative device result of “Monitor”.

Key Points: 
  • In addition, the Negative Predictive Value (NPV) of 98.1% (95% CI, 91.8%-99.6%) indicates a high level of reliability for a negative device result of “Monitor”.
  • For a positive device result of “Investigate Further”, a 1-10 score is also provided to indicate the degree of similarity to malignant lesions.
  • The study found that the likelihood of melanoma for these positive results ranged from 10.3% for low scores (i.e., 1-3) to 47.4% for high scores (i.e., 8-10).
  • This automated, objective device can help in the fight against skin cancer, and the DermaSensor team is dedicated to making a meaningful contribution to its detection and prevention."

THE PROSTATE CANCER FOUNDATION AND THE AMERICAN CANCER SOCIETY ANNOUNCE FIRST ACS-PCF YOUNG INVESTIGATOR AWARD

Retrieved on: 
Jeudi, février 22, 2024
Prostate Cancer Foundation, University College London, American Cancer Society, Doctor of Philosophy, Prostate cancer, PCF, PARP, ACS, Hospital, Geography, Mentorship, Organization, Patient, Health equity, Cone Health Women's Hospital, Research, Cancer, Partnership

LOS ANGELES, Feb. 22, 2024 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) and the American Cancer Society (ACS) today announced the ACS-PCF Young Investigator Award totaling $225,000 over three years to support a novel health equity research project that aims to reduce disparities in access to modern prostate cancer care in rural settings.

Key Points: 
  • LOS ANGELES, Feb. 22, 2024 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) and the American Cancer Society (ACS) today announced the ACS-PCF Young Investigator Award totaling $225,000 over three years to support a novel health equity research project that aims to reduce disparities in access to modern prostate cancer care in rural settings.
  • One in eight men in the U.S. will be diagnosed with prostate cancer in his lifetime, and it is the most commonly diagnosed non-skin cancer in men1.
  • "The Prostate Cancer Foundation has been funding research to understand and address prostate cancer disparities for more than 30 years," said Howard R. Soule, PhD, Executive Vice President and Chief Science Officer, PCF.
  • "We are thrilled to have Dr. Cole as our ACS-PCF Young Investigator," said William Dahut, MD, Chief Scientific Officer, American Cancer Society.